AUG 23 2023 News Releases Otsuka Medical Devices and Recor Medical Announce Positive Vote from U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on the Paradise™ Ultrasound Renal Denervation System for the Treatment of Hypertension
JUL 17 2023 News Releases ReCor Responds to European Society of Hypertension's (ESH) Updated Guidelines for Management of Arterial Hypertension (Link to ReCor website)
MAR 07 2023 News Releases Otsuka Medical Devices appoints Board Members and Audit & Supervisory Board Members
FEB 28 2023 News Releases Announces Two Concurrent JAMA Network Publications of Study Results on the Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension (Link to ReCor website)
FEB 22 2023 Information Donations to Support Relief Efforts Following Earthquakes in Turkey and Syria (Link to Otsuka Pharmaceutical website)
JAN 03 2023 News Releases ReCor Medical Names Lara Barghout President and Chief Executive Officer (Link to ReCor website)
DEC 26 2022 News Releases Otsuka Medical Devices has entered into an exclusive agreement with CSI to distribute Diamondback 360®Coronary Orbital Atherectomy System in Japan
DEC 13 2022 Information Otsuka Group Selected for CDP Climate Change A List (Link to Otsuka Holdings website)
NOV 30 2022 News Releases Submission of Application for Pre-Market Approval of the Paradise™ Ultrasound Renal Denervation (uRDN) System to the U.S. Food and Drug Administration